Collaboration between pharmacists in community pharmacy and ambulatory clinic settings: Current state and future directions
Pharmacists in the community and ambulatory settings are primed for collaboration that can optimize care. Now is the time to capitalize on the momentum and positive disruption of the COVID‐19 pandemic that propelled pharmacists and their organizations to respond with agility to deliver care in new w...
Saved in:
Published in: | JAACP : Journal of the American College of Clinical Pharmacy Vol. 6; no. 6; pp. 642 - 653 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Hoboken, USA
John Wiley & Sons, Inc
01-06-2023
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Pharmacists in the community and ambulatory settings are primed for collaboration that can optimize care. Now is the time to capitalize on the momentum and positive disruption of the COVID‐19 pandemic that propelled pharmacists and their organizations to respond with agility to deliver care in new ways, pivot to develop new partnerships, and leverage technology. The growth of collaborative practice agreements within ambulatory care settings, the enhancement of clinically integrated networks, and the growth in professional organization support create an environment ripe for implementation of pharmacist‐to‐pharmacist collaborations. The American College of Clinical Pharmacy 2022 Clinical Practice Affairs B Committee sought out literature, as well as prepublication contemporary examples, demonstrating models of intraprofessional collaboration among pharmacists in community and ambulatory settings. The committee formulated six key recommendations to optimize pharmacist collaborations in the community and ambulatory settings and formed a framework for practical implementation strategies at the levels of individual pharmacists, organizations, and educational institutions and for legislative advocacy. |
---|---|
Bibliography: | Approved by the American College of Clinical Pharmacy Board of Regents, January 20, 2023. This document was prepared by the 2022 Clinical Practice Affairs B Committee: Kelly A. Cochran, Pharm.D., BCPS (Chair); Melissa A. Somma McGivney, Pharm.D., FCCP, FAPhA (Vice Chair); Kevin Cowart, Pharm.D., MPH, BCACP, CDCES; Julie DiBridge, Pharm.D., BCPS, BCCP, BCCCP; Tiffany Dominic, Pharm.D.; Jean‐Venable R. Goode, Pharm.D., FCCP, FAPhA, BCPS; Karen Kier, Ph.D., FCCP, FASHP, BCACP, BCPS; Ha Phan, Pharm.D., BCACP, CDCES; Takova Wallace‐Gray, Pharm.D., BCACP, TTS; and Ryan Wargo, Pharm.D., BCACP. |
ISSN: | 2574-9870 2574-9870 |
DOI: | 10.1002/jac5.1796 |